ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Japan’s AGC buys drug chemical plant in Spain

by Rick Mullin
December 16, 2018 | APPEARED IN VOLUME 96, ISSUE 49

 

09649-buscon13-agccxd.jpg
Credit: AGC
Malgrat's plant is on the ocean in Catalonia, Spain.

AGC, a Japanese glass, chemical, and high-tech materials firm, will acquire Malgrat Pharma Chemicals, an active pharmaceutical ingredient (API) maker in Catalonia, Spain, from Boehringer Ingelheim. The acquisition will give AGC its first US Food and Drug Administration–registered site in Europe. Earlier this year, AGC announced a near-10-fold increase in production capacity at its API plant in Chiba, Japan, expected to come on line by the end of next year.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment